The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus surgery-first for resectable pancreatic carcer (Prep-02/JSAP05).
 
Michiaki Unno
Honoraria - Astellas Pharma; Chugai Pharma; Eisai; Janssen; Lilly; Novartis; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma (Inst); Janssen (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Fuyuhiko Motoi
No Relationships to Disclose
 
Tomoo Kosuge
No Relationships to Disclose
 
Hideki Ueno
Honoraria - Lilly; Taiho Pharmaceutical
Research Funding - Lilly; Taiho Pharmaceutical
 
Hiroki Yamaue
No Relationships to Disclose
 
Sohei Satoi
No Relationships to Disclose
 
Masayuki Sho
No Relationships to Disclose
 
Goro Honda
No Relationships to Disclose
 
Ippei Matsumoto
No Relationships to Disclose
 
Keita Wada
No Relationships to Disclose
 
Junji Furuse
Honoraria - Ajinomoto; Astellas Pharma; Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Dainippon Sumitomo Pharma; Eisai; Hisamitsu Pharmaceutical; Kyowa Hakko Kirin; Lilly; Meiji Seika Kaisha; Merck Serono; Mitsubishi Tanabe Pharma; Nippon Kayaku; Ono Pharmaceutical; Sandoz; Sanofi; Shionogi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Chugai Pharma; Eisai; Fujifilm; GlaxoSmithKline; Janssen; Kowa; Kyowa Hakko Kirin; Merck Serono; Otsuka; Taiho Pharmaceutical; Yakult Honsha; Zeria Pharmaceutical
Research Funding - Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck Serono (Inst); Nippon Kayaku (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Torii Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Tohru Furukawa
No Relationships to Disclose
 
Kazuyuki Ishida
No Relationships to Disclose
 
Kei Takase
No Relationships to Disclose
 
Yutaka Matsuyama
No Relationships to Disclose
 
Kei Nakagawa
No Relationships to Disclose
 
Yu Katayose
No Relationships to Disclose